v3.24.1.u1
Financial Statements Details
 3 Months Ended
Mar. 31, 2024
Balance Sheet Components [Abstract]  
Financial Statements Details Financial Statements Details
Cash, Cash Equivalents and Restricted Cash
    The reconciliation of cash, cash equivalents and restricted cash reported on the unaudited condensed consolidated balance sheets to the total of the same such amounts in the unaudited condensed consolidated statements of cash flows is as follows (in thousands):
March 31, 2024December 31, 2023
Cash and cash equivalents$2,092,101 $1,938,606 
Restricted cash included in other assets860 858 
 Total cash, cash equivalents and restricted cash$2,092,961 $1,939,464 
Accounts Receivable, net
    Accounts receivable, net consists of the following (in thousands):
March 31, 2024December 31, 2023
Accounts receivable $1,098,983 $1,034,480 
Product sales rebate and returns reserve(8,942)(9,911)
   Accounts receivable, net $1,090,041 $1,024,569 
Inventories
    Inventories consist of the following (in thousands):
March 31, 2024December 31, 2023
Raw materials $979,947 $930,777 
Finished goods 1,045,257 1,014,403 
   Total inventories $2,025,204 $1,945,180 
Property and Equipment, net
    Property and equipment, net consists of the following (in thousands):
March 31, 2024December 31, 2023
Land$45,160 $44,645 
Equipment and machinery 152,410 144,850 
Computer hardware and software 58,448 57,761 
Leasehold improvements
34,706 34,584 
Furniture and fixtures 3,563 3,576 
Construction-in-process 338 4,242 
    Property and equipment, gross 294,625 289,658 
Less: accumulated depreciation (196,676)(188,078)
    Property and equipment, net $97,949 $101,580 
    Depreciation expense was $8.6 million and $7.1 million for the three months ended March 31, 2024 and 2023, respectively.
Accrued Liabilities
    Accrued liabilities consist of the following (in thousands):
March 31, 2024December 31, 2023
Accrued compensation-related costs$62,920 $134,225 
Accrued supplier liability95,392 167,878 
Accrued manufacturing costs61,036 61,491 
Accrued product development costs10,063 1,041 
Other41,175 42,667 
   Total accrued liabilities $270,586 $407,302 
Contract Liabilities, Deferred Revenue and Other Performance Obligations    
Contract Liabilities
    A contract liability is recognized when we have received customer payments in advance of our satisfaction of a performance obligation under a cancellable contract. The following table summarizes the activity related to our contract liabilities (in thousands):
Three Months Ended March 31,
20242023
Contract liabilities, beginning balance$133,239 $103,448 
Less: Revenue recognized from beginning balance(12,000)(9,243)
Less: Beginning balance reclassified to deferred revenue(6,498)(4,382)
Add: Contract liabilities recognized24,877 15,224 
Contract liabilities, ending balance$139,618 $105,047 
    As of March 31, 2024 and December 31, 2023, $59.4 million and $59.2 million of our contract liabilities, respectively, were included in "Other current liabilities" with the remaining balances included in "Other long-term liabilities" on the condensed consolidated balance sheets.
Deferred Revenue
    Deferred revenue is comprised mainly of unearned revenue related to multi-year post-contract support ("PCS") contracts, services and product deferrals related to contracts with acceptance clauses. The following table summarizes the activity related to our deferred revenue (in thousands):
Three Months Ended March 31,
20242023
Deferred revenue, beginning balance
$1,506,204 $1,041,246 
Less: Revenue recognized from beginning balance(284,283)(214,450)
Add: Deferral of revenue in current period, excluding amounts recognized during the period441,321 265,478 
Deferred revenue, ending balance$1,663,242 $1,092,274 
Other Performance Obligations
    Other performance obligations totaling $809.0 million as of March 31, 2024 include unbilled multi-year PCS and service contract amounts of $543.5 million and $265.5 million of binding contractual agreements with certain customers that are primarily related to future product shipments.
Revenue from Total Remaining Performance Obligations
    Total revenue from our contract liabilities, deferred revenue and other performance obligations that is expected to be recognized in future periods amounts to $2.6 billion as of March 31, 2024. Approximately 79% of this future revenue is expected to be recognized over the next two years and the remaining 21% is expected to be recognized during the third to the fifth year.
Other Income (Expense), net
    Other income (expense), net consists of the following (in thousands):
Three Months Ended March 31,
20242023
Interest income$63,823 $22,509 
 Gain (loss) on strategic investments— (5,571)
Other income (expense), net(1,203)(4,792)
    Total$62,620 $12,146